ADD-Has Minimal Residual Disease (MRD) testing been approved by the FDA yet? - 101867

Spotlight
Video

ADD-Has Minimal Residual Disease (MRD) testing been approved by the FDA yet?

Loading........
Description: In this week’s video, Dr. Brian GM Durie explains that the FDA will soon consider MRD-testing as a surrogate endpoint for both newly diagnosed and relapsed myeloma patients.

BOTTOM LINE:

It is very likely that the FDA will approve both tests—NGS and NGF—within the next 1–2 years.
Shared By : InternationalMyelomaFoundation
Posted on : 08/25/17
Added : 5 months ago
Category : Multiple Myeloma



Recommended

Nothing found.